ecrin-mdr-crcClinical2003AdenocarcinomaColorectal CancerAdenocarcinomaColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2010410United States12Recurrent rectal cancerRecurrent colon cancerIrinotecanStage IV rectal cancerOxaliplatinLeucovorinStage IV colon cancerAdenocarcinoma of the colonCetuximabAdenocarcinoma of the rectumFluorouracilECRIN MDRTerminatedfalseFOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or RectumThis is a randomized phase II study trial that has served as a screening trial to test the increased efficacy of chemotherapy + cetuximab versus chemotherapy alone among patients with untreated, advanced or metastatic colon cancer regardless of tumor status with respect to EGFR.2003-12-152010410NCT00077233